Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127450863 | 12745086 | 3 | F | 2016 | 20160916 | 20160915 | 20160926 | EXP | US-CELGENEUS-USA-2016092934 | CELGENE | 0.00 | F | Y | 58.11000 | KG | 20160926 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127450863 | 12745086 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | 200 MILLIGRAM | U | U | UNKNOWN | 20785 | 200 | MG | CAPSULES | QD | |||
127450863 | 12745086 | 2 | C | NEUPOGEN | FILGRASTIM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127450863 | 12745086 | 1 | Plasma cell myeloma |
127450863 | 12745086 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127450863 | 12745086 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127450863 | 12745086 | Drug ineffective | |
127450863 | 12745086 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127450863 | 12745086 | 1 | 20160713 | 0 |